Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Get weekly health news The health regulator said it had received reports of adverse events, with some requiring hospitalization, that may be related to overdoses due to patients incorrectly self-administering the compounded drug and health-care providers miscalculating doses
In December, Gilead had said it will not pursue US approval of filgotinib in rheumatoid arthritis
The three brands combinedOzempic, Wegovy and Rybelsussold $36.19 billion, outpacing Mercks long-time bestseller cancer drug Keytruda as the best-selling medicine of 2025
Benchmarking second and third-generation sequencing platforms for microbial metagenomics
US$ 20.47
US$ 28.83
US$ 22.93
US$ 29.73
US$ 21.44
